Interview: Yi-cheh Chiu, Director General, Department of Investment Services,…
The General Director of the ‘Invest in Taiwan’ program discusses Taiwan’s competitiveness on a…
Department of Investment Services, Taiwan
Last updated: 13.02.2014
The Department of Investment Services is a staff unit of the Ministry of Economic Affairs, charged with the promotion of foreign investment in Taiwan, the encouragement of Taiwanese business to return from overseas and invest in Taiwan, the guidance of domestic enterprises in investing overseas, and the recruitment of foreign talent.
These are the main DOIS tasks:
- Promotion of foreign investment in and technical cooperation with Taiwan
- Encouragement of and assistance for Taiwanese businesses overseas to return and invest in Taiwan
- Guidance and assistance for outward investment
- Pinpointing and compilation of investment opportunities
- Implementation of investment projects, follow-up, and removal of obstacles to investment
- Publishing of investment guides and investment-related laws and regulations
- Recruitment of overseas professionals
- Promotion and liaison regarding bilateral and multilateral investment matters
8th Fl., 71 Guanqian Rd., Taipei 10047, Taiwan, R.O.C.
Tel: 886-2-2389-2111
Fax: 886-2-2382-0497
E-mail: investtw@moea.gov.tw
Website: http://www.dois.moea.gov.tw
Interviews
Related
Charles Chen – Vice Chairman & CEO, Medigen Vaccine Biologics Corp.…
Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s…
Johnsee Lee – Chairman & CEO & Eric Yang – VP, Quark…
Johnsee Lee and Eric Yang of Taiwanese precision medicine diagnostics firm Quark Biosciences outline their…
Louis Cheng – CEO, Leadgene Biomedical, Taiwan
Louis Cheng, CEO of Taiwanese firm Leadgene Biomedical, introduces the company’s expertise in antibody…
Johnsee Lee – Chairman, Taiwan Bio Industry Organization; President &…
Taiwan Bio Industry Organization Chairman Dr Johnsee Lee outlines the Taiwanese biopharmaceutical industry’s…
First Impressions / Taiwanese Pharma
Taiwan, although small in size, boasts a strong culture of innovation as well as a universal healthcare system that…
Report / New Taiwan Pharma Report November 2019 Out Now
Long overshadowed by larger and more well-known neighbours, the island of Taiwan is nonetheless cultivating an…
APAC / Taiwanese Pharma Looking Locally for International Opportunities
While Taiwanese pharmaceutical and biotech players have traditionally set their sights on the US as a key market,…
Talent / Multinationals' HR Strategies in Taiwan
All country managers of multinational pharma companies need to strike the balance between having a global outlook…
Stanley Huang – Founder & Managing Director, Nutrarex Biotech, Taiwan
Nutrarex Biotech is a Taiwanese private label contract manufacturer of functional supplements, exclusively…
APAC / Taiwan's New Southbound Policy: Enhancing Regional Ties
In an effort to enhance trade and cooperation with other countries in the region and reduce dependency on mainland…
Company Profile / iXensor, Taiwan
Within Taiwan’s evolving medical device sector, many innovative startups are exploring breakthrough ideas which…
Mark Yang – CEO, GaleMed, Taiwan
Mark Yang, CEO of GaleMed, elaborates on the medical device manufacturer’s transition from a privately-owned…
